PHIA Koninklijke Philips N.V.

Philips convenes the Annual General Meeting of Shareholders 2025

Philips convenes the Annual General Meeting of Shareholders 2025

March 24, 2025



Amsterdam, the Netherlands –
(NYSE: PHG, AEX: PHIA) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2025 and published the agenda with explanatory notes.



As previously announced, the agenda includes:



  • Proposal to appoint Mr Bob White (American, 1962) as a new member of the Supervisory Board, with effect from May 8, 2025.
  • Proposals to re-appoint Ms Indra Nooyi (American, 1955) and Ms Chua Sock Koong (Singaporean, 1957) as members of the Supervisory Board, with effect from May 8, 2025.
  • Proposal to re-appoint Mr Marnix van Ginneken (Dutch, 1973) as a member of the Philips Board of Management, with effect from May 8, 2025. 



The agenda furthermore includes a number of recurring items, such as the 2024 Remuneration Report as included in the Annual Report 2024 (advisory vote), and the proposals to adopt the company’s financial statements and dividend.



The AGM will be held at the Hotel Okura Amsterdam, Ferdinand Bolstraat 333, Amsterdam on Thursday, May 8, 2025, beginning at 14:00 CET.



The complete agenda with explanatory notes, the Annual Report 2024 (which was published on February 21, 2025), the binding nominations and other information relevant for the AGM have been published .

For further information, please contact:





Michael Fuchs

Philips Global External Relations

Tel.:

E-mail:



Dorin Danu

Philips Investor Relations

Tel.:

E-mail:

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18.0 billion and employs approximately 67,800 employees with sales and services in more than 100 countries. News about Philips can be found at .



Forward-looking statements


This release contains certain forward-looking statements with respect to the financial condition, results of operations and business of Philips and certain of the plans and objectives of Philips with respect to these items. Examples of forward-looking statements include statements made about the strategy, estimates of sales growth, future EBITA, future developments in Philips’ organic business and the completion of acquisitions and divestments. By their nature, these statements involve risk and uncertainty because they relate to future events and circumstances and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these statements.

Attachments



EN
24/03/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

Oliver Metzger ... (+3)
  • Oliver Metzger
  • Usama Tariq
  • Wim Gille
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Allfunds Group PLC: Ready to Spring forward. Basic-Fit: 1H25 ahead of INGF, membership ingrowth, outlook reiterated, FCF a bit light. Lotus Bakeries: Preview 1H25. NN Group & ASR: Dutch Pension Reform not an issue at 29 October Dutch elections. Philips: 2Q25 results, much lower tariff impact. Proximus: New BICS CEO and Global CRO laid off. Vastned: Good results, EPRA EPS guidance up by 2.5%. Zabka: 2Q25 Preview

Oscar Rodriguez
  • Oscar Rodriguez

PHILIPS: RDOS. 2T’25 (ANÁLISIS BANCO SABADELL)

Rdos. 2T'25 vs 2T'24: Ventas: 4.338 M euros (-2,8% vs -3,2% BS(e) y -3,5% consenso); EBITA Ajustado: 540 M euros (+9,1% vs -17,2% BS(e) y -13,5% consenso); BDI: 240 M euros (-46,9% vs -80,5% BS(e) y -77,7% consenso).

ResearchPool Subscriptions

Get the most out of your insights

Get in touch